Farms.com Home   News

WCA research trial looks at managing drought risk by using split applications of N

Farmers taking part in this week's Cropportunities event learned what goes on behind the scenes in setting up a research trial with Wheatland Conservation Area (WCA).

WCA Farm Manager Bryan Nybo also talked about one of the research trials from last year looking at 'Managing Drought Risk Using Split Applications Of Nitrogen'.

Nybo says the trial was developed after producers who had been dealing with an ongoing drought, were asking if in a dry year, they could hold back on nitrogen at seeding time to save money, and then if it did rain later use a dual-band or post-emergent N to support higher yield potentials without being penalized.

He says they wanted to evaluate the results under dry and wet conditions and ran the trial at two different locations with Swift Current being the dry site, and Outlook running the same trial but under wet conditions.

"At Swift, we basically looked at can we save money by holding back nitrogen at seeding time? Our results showed very little yield response to increasing rates of nitrogen. We did show negative rates of return on fertilizer investment was the case in Swift Current. So we sure could save money. "

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.